| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.76M | $1.51M | $2.05M | $3.75M | $670.61K |
| R&D | $281.01K | $138.32K | $139.66K | $266.93K | $73.33K |
| SG&A | $1.48M | $1.37M | $1.91M | $3.48M | $597.28K |
| Operating Income | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$670.61K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$1.76M | -$1.51M | -$2.05M | -$3.75M | -$670.61K |
| EPS (basic) | -0.1200 | -0.1300 | -0.1800 | -0.3400 | -0.0700 |
| EPS (diluted) | -0.1200 | -0.1300 | -0.1800 | -0.3400 | – |
| Shares (diluted) | $15.23M | $11.44M | $11.35M | $11.02M | – |